Could a $10 arthritis pill tame rare blood cancers?
NCT ID NCT06541249
First seen Jan 09, 2026 · Last updated Jun 13, 2026 · Updated 27 times
Summary
This study tests whether low-dose methotrexate, a safe and inexpensive arthritis drug, can help people with certain blood cancers (polycythemia vera, essential thrombocythemia, and myelofibrosis). About 54 adults will take the drug alongside their current treatment to see if it shrinks the spleen, improves symptoms, and lowers blood counts. If it works, it could offer a low-cost option for patients who cannot afford newer, expensive drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA (PV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruttenberg Treatment Center
RECRUITINGNew York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.